ST. LOUIS--(BUSINESS WIRE)--GenoMed (OTC Pink Sheets:GMED), the Next Generation Disease Management company whose business is public health™, announced today publication of a case report of a sickle cell patient whose pain has disappeared for over a year thanks to GenoMed's treatment.
